Gene · 6326
Papers4,098
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 4,098
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Red Blood Cell-Improving Transfusions for Chronically Transfused Recipients (RBC-IMPACT) study: protocol description of an international multi-site observational clinical study. | Blood Transfus | 2025 | 40423585 | PubTator, text mining | PubMed |
| Hb Lepore Rochester-MN, a novel βδβ double crossover hemoglobin variant. | Blood Cells Mol Dis | 2025 | 40413840 | PubTator, text mining | PubMed |
| Association of SCN2A single nucleotide polymorphisms with Parkinson's disease: evidence from a case-control study. | Int J Neurosci | 2025 | 40389383 | PubTator, text mining | PubMed |
| Continuous non-contact vital sign monitoring of neonates in intensive care units using RGB-D cameras. | Sci Rep | 2025 | 40374723 | PubTator, text mining | PubMed |
| [Clinical and genetic characteristics of SCN2A gene related developmental delay]. | Zhonghua Yu Fang Yi Xue Za Zhi | 2025 | 40374357 | PubTator, text mining | PubMed |
| [Epilepsy: Genetic Insights and Advances in Gene Therapies]. | Brain Nerve | 2025 | 40350643 | PubTator, text mining | PubMed |
| Single-Cell Profiling of Mononuclear Cells Identifies Transcriptomics Signatures Differentiating Prostate Cancer From Benign Prostatic Hyperplasia. | Genes Chromosomes Cancer | 2025 | 40346907 | PubTator, text mining | PubMed |
| Increased expression of FGF14 and SCN2A/SCN11A is associated with better survival of HCC patients. | Tumori | 2025 | 40329566 | PubTator, text mining | PubMed |
| Precision Therapeutics in Lennox-Gastaut Syndrome: Targeting Molecular Pathophysiology in a Developmental and Epileptic Encephalopathy. | Children (Basel) | 2025 | 40310132 | PubTator, text mining | PubMed |
| Discovery of novel 4-azaindole derivatives as selective Nav1.2 Inhibitor with potent antiepileptic activity and low neurotoxicity. | Eur J Med Chem | 2025 | 40305939 | PubTator, text mining | PubMed |
| Antisense oligonucleotide treatment in a preterm infant with early-onset SCN2A developmental and epileptic encephalopathy. | Nat Med | 2025 | 40263630 | PubTator, text mining | PubMed |
| Oxcarbazepine may be an effective option for Chinese pediatric patients with self-limited focal epilepsy of neonatal/infantile onset: a retrospective cohort study. | Front Pediatr | 2025 | 40236662 | PubTator, text mining | PubMed |
| Small SNPs, Big Effects: A Review of Single Nucleotide Variations and Polymorphisms in Key Genes Associated With Autism Spectrum Disorder. | Int J Dev Neurosci | 2025 | 40223535 | PubTator, text mining | PubMed |
| Precision medicine approach for in vitro modeling and computational screening of anti-epileptic drugs in pediatric epilepsy patients with SCN2A (R1629L) mutation. | Comput Biol Med | 2025 | 40198980 | PubTator, text mining | PubMed |
| Multiple molecular diagnoses identified through genome sequencing in individuals with suspected rare disease. | HGG Adv | 2025 | 40195116 | PubTator, text mining | PubMed |
| SNAP25 variant I67N: synaptic phenotypes, drug response and proteome changes in human neurons. | Brain | 2025 | 40181518 | PubTator, text mining | PubMed |
| Generation of an integration-free induced pluripotent stem cell line, MURAi006-A, from a hemoglobin E/β-thalassemia patient harboring the βE/β0 (Codon 17, A > T) compound heterozygous mutation. | Stem Cell Res | 2025 | 40179812 | PubTator, text mining | PubMed |
| Alternative splicing analysis in a Spanish ASD (Autism Spectrum Disorders) cohort: in silico prediction and characterization. | Sci Rep | 2025 | 40155475 | PubTator, text mining | PubMed |
| Neural Excitatory/Inhibitory Imbalance in Motor Aging: From Genetic Mechanisms to Therapeutic Challenges. | Biology (Basel) | 2025 | 40136528 | PubTator, text mining | PubMed |
| Prevalence and Detection of Novel Thalassemia Variant hemoglobin J in Extensive Tharu Population. | Ann Afr Med | 2025 | 40123127 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6326/papers?page=9